This wiki has undergone a migration to Confluence found Here
Difference between revisions of "Structured Product Labeling"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
Return to [[Regulated Clinical Research Information Management|RCRIM]] main page | Return to [[Regulated Clinical Research Information Management|RCRIM]] main page | ||
| − | == Project Scope | + | == Project Scope == |
| − | [http:// | + | [http://svn.hl7.nscee.edu/svn/hl7v3/rcrim/trunk/Project%20Scope%20Statements/2007JAN_PROJSCOPE_RCRIM_randy_levin_SPL_r3_Implementation_Guide_20060922105939%5B1%5D.doc SPLr4 IG Project Scope] |
| − | + | [http://svn.hl7.nscee.edu/svn/hl7v3/rcrim/trunk/Project%20Scope%20Statements/2007SEP_PROJSCOPE_RCRIM_edward_tripp_Structured%20Product%20Labe.doc SPLr4 Message Project Scope] | |
| − | Document Reviews | + | |
| + | ==Subteams and Supporting Materials == | ||
| + | [http://spl-work-group.wikispaces.com SPL Work Group Wiki] | ||
| + | |||
| + | ==Document Reviews== | ||
*[[SPL Implementation Guide]] | *[[SPL Implementation Guide]] | ||
| Line 13: | Line 17: | ||
*[[SPL Validation Rules]] | *[[SPL Validation Rules]] | ||
| + | ==Related Project== | ||
| + | [[Medical Product and Device Listing]] | ||
== Open Discussion Items: == | == Open Discussion Items: == | ||
Revision as of 16:28, 10 February 2009
Return to RCRIM main page
Contents
Project Scope
Subteams and Supporting Materials
Document Reviews
03-Nov-2008: Draft sent for ballot (for Jan 2009); FDA reviewing proposed changes this month.
Related Project
Medical Product and Device Listing
Open Discussion Items:
Technical Team Meeting Dial-in Information:
SPL Technical Team Call(for Regulated Clinical Research Information Management) Call is scheduled for 1.0 hour
Alternate Mondays 02:00 PM (US Eastern Time, GMT -4 DST)
Please consult http://www.timeanddate.com/worldclock for your local times
Participation Information
Phone Number: 770-657-9270 Participant Passcode: 745896
Contact fontaine@pharmiceutics.com or keith.thomas@utoronto.ca for agenda and additional information.
